Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Olema Pharmaceuticals, Inc. (OLMA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/23/2022 |
4/A
| Bohen Sean (PRESIDENT AND CEO) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Bought 20,000 shares
@ $0 |
|
| 06/27/2022 |
4/A
| Larson Yi (Director) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Granted 21,520 options to buy
@ $0 |
|
| 06/27/2022 |
4/A
| Horning Sandra (Director) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Granted 21,520 options to buy
@ $0 |
|
| 06/27/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/27/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/27/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/27/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/27/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 11/20/2020 |
4/A
| Graham G. Walmsley (Director) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Bought 339,578 convertible preferred
@ $4.7117, valued at
$1.6M
|
|
| 11/20/2020 |
4/A
| Harmon Cyrus (Chief Technology Officer) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Granted 1,076 options to buy
@ $19, valued at
$20.4k
|
|
|
|